Evonik stock steadies as coatings demand improves in Q3

Published on 11/11/2026 at 12:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evonik stock faces a stronger coatings backdrop as pricing offsets raw-material pressure. The company is also advancing portfolio changes and efficiency measures.

What the third quarter signals

Custom Solutions benefited from firmer demand and pricing in its additives businesses.
Advanced Technologies delivered a sharp increase in sales and adjusted EBITDA, supported by volumes, prices and efficiency measures.
Evonik expects full-year adjusted EBITDA in the upper half of its guidance range while portfolio sales progress.

Evonik, DE000EVNK013, Illustration mit AI erstellt.

Evonik reported improved demand for additives used in paints and coatings during the third quarter, while higher selling prices helped offset rising raw-material costs. PCI Magazine described the development in a report published on Wednesday, November 11, 2026, highlighting stronger activity in selected specialty-chemical markets.

Evonik stock traded at 20.77 euros on Lang & Schwarz at 12:31 CET on Wednesday, November 11, 2026, 0.05 percent below the Xetra close of Tuesday, November 10, 2026 at 20.78 euros.

Pricing supports specialty chemicals

Evonik's Custom Solutions segment, which includes the additives businesses, generated sales of 1.39 billion euros in the third quarter, an increase of 4 percent from the prior-year period. Adjusted EBITDA rose 7 percent to 231 million euros, and the segment's adjusted EBITDA margin improved to 16.6 percent from 16.0 percent.

PCI Magazine reported a positive demand trend for products serving paints and coatings as well as oil additives. Selling prices increased and overall Additives sales rose considerably. The segment figures cover more than coatings additives alone, so they do not represent a separate coatings-only sales or earnings measure.

PCI Magazine's report also pointed to continued positive development in crosslinkers within Advanced Technologies. The segment increased sales 19 percent to 1.71 billion euros, while adjusted EBITDA advanced 87 percent to 377 million euros. The business serves several markets beyond coatings, making the segment figures a broader indicator of operating momentum.

Outlook remains in the upper range

Across the group, third-quarter sales increased 13 percent to 3.83 billion euros. The improvement reflected a 10 percent rise in selling prices and 2 percent higher volumes. Group adjusted EBITDA increased 40 percent to 629 million euros.

Evonik expects full-year adjusted EBITDA to come in the upper half of its guidance range of 2.0 billion to 2.2 billion euros. For investors, the combination of firmer demand, pricing support and higher volumes points to improved operating traction, although the company remains exposed to raw-material costs and uneven demand across end markets.

Portfolio restructuring remains part of the investment case. The company said the sale process for its Oxeno C4 chemicals business is progressing, with a buyer expected to be announced in the coming months. Preparations have also begun for a possible sale of Syneqt, which operates chemical parks in Marl and Wesseling. No buyer or definitive transaction had been announced in the PCI Magazine report.

Evonik recorded 313 million euros in third-quarter provisions linked to its Tailor Made efficiency program and plans to extend the program through 2029. Those charges weigh on reported earnings even as adjusted operating performance improves, so investors will continue to watch the balance between restructuring costs and recurring profitability.